Background: Ischemia-modified albumin has been proposed as a useful rule-out marker for
the diagnosis of acute coronary syndrome in the emergency department. Objective: To …

INTRODUCTION: Ischemia-modified albumin (IMA) has been proposed as a useful rule-out
marker for the diagnosis of acute coronary syndrome (ACS) in the emergency department …

Background: The diagnosis of acute coronary syndrome remains challenging, as cardiac
troponins and creatine kinase-MB do not detect myocardial ischemia. Ischemia modified …

The early diagnosis of acute coronary syndrome remains problematic, despite recent
improvements. Traditionally, the diagnosis of acute cardiac ischaemia relies on the …

Ischemia modified albumin (IMA) is a relatively new marker for evaluating patients with
cardiac ischemia. Data are emerging on its potential role in non-cardiac ischemic events. In …

Background: An early identification of the patients with the Acute Coronary Syndrome (ACS)
is of prime importance, due to the associated very high mortality. Only about 22% of the …

Background: Ischemia-modified albumin (IMA) has been suggested as a marker of cardiac
ischemia. Little, however, is known about its capacity to predict short-term serious cardiac …

To improve prognosis in acute coronary syndrome, new clinical applications in terms of
diagnosis, risk stratification, and treatment strategies are still under investigation. Ischemia …

BACKGROUND: Existing cardiac markers are not sensitive for reversible myocardial
ischemia. Ischemia modified albumin (IMA) has recently been shown to be an early and …

ABSTRACT Aims and Objectives: To find out if ischemia modified albumin can be a novel
marker in ischemic heart disease. Materials and methods: Retrospective chart-review of …